Related Experiment Video

Updated: Aug 7, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Melanoma cell growth inhibition and melanocortin receptor downregulation induced by selective and non-selective

W Siegrist1, E Hintermann, C N Roggo

  • 1Department of Research (ZLF), University Hospital, Basel, Switzerland.

Melanoma Research
|June 4, 1998
PubMed

Insights

Retinoic acid receptor (RAR)-gamma-selective retinoids show significant potential for melanoma treatment by inhibiting cancer cell growth. These compounds effectively reduce melanoma cell proliferation and downregulate melanocortin receptor 1 (MC1-R) expression.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Melanoma is a significant form of skin cancer.
  • Retinoids are vitamin A derivatives with therapeutic potential.
  • Retinoid receptors, including RAR and RXR, play roles in cell growth and differentiation.

Purpose of the Study:

  • To investigate the impact of retinoid analogues with varying receptor specificity on melanoma cell growth.
  • To compare the growth inhibitory effects with the modulation of cell surface melanocortin receptor 1 (MC1-R) expression.

Main Methods:

  • Utilized human D10 and Cloudman S91 mouse melanoma cell lines.
  • Administered retinoid analogues selective for retinoic acid receptor (RAR)-alpha, -beta, -gamma, and retinoid X receptor (RXR).
  • Assessed cell growth inhibition and MC1-R surface expression levels.

Main Results:

  • RARgamma-selective retinoids demonstrated the most potent growth inhibition (up to 69%) in both cell lines.
  • RXR-selective retinoids showed minimal growth inhibition (14-23%).
  • MC1-R downregulation varied significantly by cell type and retinoid selectivity, with RARgamma-selective retinoids being most effective in D10 cells and RXR-selective retinoids in S91 cells.

Conclusions:

  • RARgamma-selective retinoids exhibit promising therapeutic potential for melanoma treatment.
  • The distinct selectivity profiles for growth inhibition and MC1-R downregulation in S91 cells suggest these effects are not directly linked.
  • Further research into RARgamma-selective retinoids is warranted for melanoma therapy development.

More Related Videos

Quantification of Hypopigmentation Activity In Vitro06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...